ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Asan Medical Center at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Asan Medical Center takes part in 4 sessions at ESMO 2026 in Madrid. Its work focuses on biliary tract cancer and rare endocrine cancers, including treatment combinations and factors linked to response. It examines maintenance olaparib with or without durvalumab in advanced biliary tract cancer with DNA repair gene mutations.

OrganizationESMO 2026 Attendance
Asan Medical Center
Seoul, Republic of Korea
Cancer centre & hospital
Teaching hospital of the University of Ulsan College of Medicine in Seoul, South Korea.
Poster
Fri Oct 23
15:15–16:00
Abstract
Fri Oct 23
16:50–16:55
Poster
Sun Oct 25
12:00–12:45
Integrated multi-omic profiling of biliary tract cancer identifies genomic and immune determinants of response to First-line GemCis-ICI
Sunday Poster Display session 2
Gastrointestinal cancersBiomarkers & precision oncology
Abstract
Mon Oct 26
15:29–15:34

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Asan Medical Center

Tell us what you sell and we’ll find the people at Asan Medical Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction